Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-17-009898
Filing Date
2017-02-13
Accepted
2017-02-13 13:49:58
Documents
1
Period of Report
2017-02-09

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 3965
  Complete submission text file 0001209191-17-009898.txt   5456
Mailing Address C/O PHARMACYCLICS, INC. 995 EAST ARQUES AVENUE SUNNYVALE CA 94085
Business Address
Zanganeh Maky (Reporting) CIK: 0001507650 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-37744 | Film No.: 17597926

Mailing Address 849 MITTEN ROAD SUITE 104 BURLINGAME CA 90401
Business Address 849 MITTEN ROAD SUITE 104 BURLINGAME CA 90401 650-697-3939
Pulse Biosciences, Inc. (Issuer) CIK: 0001625101 (see all company filings)

EIN.: 000000000 | State of Incorp.: NV | Fiscal Year End: 1217
SIC: 3841 Surgical & Medical Instruments & Apparatus